Pengcheng Zhang, Xiaoyu Wang, Zhipeng Sai, Conghui Lu, Yan Yang, Zhijun Yang, Chunpo Ge
{"title":"A rapid-response red-emitting probe for peroxynitrite fluctuation and silymarin protection in drug-induced hepatotoxicity","authors":"Pengcheng Zhang, Xiaoyu Wang, Zhipeng Sai, Conghui Lu, Yan Yang, Zhijun Yang, Chunpo Ge","doi":"10.1016/j.bioorg.2025.108986","DOIUrl":null,"url":null,"abstract":"<div><div>Drug-induced liver injury (DILI) is a clinically important condition caused by hepatotoxic drugs or their reactive metabolites, frequently linked to excessive reactive oxygen species (ROS) generation. Given the pivotal role of peroxynitrite (ONOO<sup>−</sup>) in oxidative stress-mediated DILI progression, real-time tracking of its spatial-temporal dynamics is critical for mechanistic studies. We present a red-emitting fluorescent probe, LD-ONOO, engineered with a naphthylamide-based fluorophore and a phenylboronic acid pinacol ester as the ONOO<sup>−</sup>-specific trigger. This probe demonstrates ultrafast response kinetics (<30 s), a remarkably large Stokes shift (163 nm), and exceptional selectivity and sensitivity for ONOO<sup>−</sup> over competing ROS. LD-ONOO enabled real-time monitoring of endogenous ONOO<sup>−</sup> fluctuations in both cellular and zebrafish models. In vivo imaging in a DILI mouse model revealed pronounced ONOO<sup>−</sup> upregulation, directly implicating its pathological role. Notably, silymarin treatment effectively normalized ONOO<sup>−</sup> levels, demonstrating the therapeutic potential of this traditional Chinese medicine-derived compound in mitigating DILI. Our study not only delivers a versatile molecular imaging tool for investigating ONOO<sup>−</sup>-associated hepatotoxicity but also provides experimental validation for the application of natural compounds in DILI intervention strategies.</div></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"165 ","pages":"Article 108986"},"PeriodicalIF":4.7000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0045206825008661","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Drug-induced liver injury (DILI) is a clinically important condition caused by hepatotoxic drugs or their reactive metabolites, frequently linked to excessive reactive oxygen species (ROS) generation. Given the pivotal role of peroxynitrite (ONOO−) in oxidative stress-mediated DILI progression, real-time tracking of its spatial-temporal dynamics is critical for mechanistic studies. We present a red-emitting fluorescent probe, LD-ONOO, engineered with a naphthylamide-based fluorophore and a phenylboronic acid pinacol ester as the ONOO−-specific trigger. This probe demonstrates ultrafast response kinetics (<30 s), a remarkably large Stokes shift (163 nm), and exceptional selectivity and sensitivity for ONOO− over competing ROS. LD-ONOO enabled real-time monitoring of endogenous ONOO− fluctuations in both cellular and zebrafish models. In vivo imaging in a DILI mouse model revealed pronounced ONOO− upregulation, directly implicating its pathological role. Notably, silymarin treatment effectively normalized ONOO− levels, demonstrating the therapeutic potential of this traditional Chinese medicine-derived compound in mitigating DILI. Our study not only delivers a versatile molecular imaging tool for investigating ONOO−-associated hepatotoxicity but also provides experimental validation for the application of natural compounds in DILI intervention strategies.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.